The Price of Gleevec: A Tale of Two Supreme Courts
Americans interested in generic drug prices and pharmaceutical patent law have been closely following the U.S. Supreme Court as it hears arguments in a case over “pay-for-delay” – the practice of...
View ArticleOpen Season on Pay-To-Delay After New Supreme Court Decision
This week, the U.S. Supreme Court ruled in favor of consumers over drug companies by ruling that pay-to-delay tactics by pharmaceutical companies could violate antitrust laws. This could mean speedier...
View ArticleThe Prices We Pay for Delay
Brand name drug manufacturers made an estimated $98 billion in sales over the past eight years by paying generic manufacturers to postpone selling low-cost generic drugs, according to a new report...
View ArticleClik here to view.
The Price of Gleevec: A Tale of Two Supreme Courts
Gleevec 400 mg tablets photo credit: Patrick Pelletier Creative Commons CC-BY-SA-3.0 Americans interested in generic drug prices and pharmaceutical patent law have been closely following the U.S....
View ArticleClik here to view.
Open Season on Pay-To-Delay After New Supreme Court Decision
This week, the U.S. Supreme Court ruled in favor of consumers over drug companies by ruling that pay-to-delay tactics by pharmaceutical companies could violate antitrust laws. This could mean speedier...
View ArticleClik here to view.
The Prices We Pay for Delay
Brand name drug manufacturers made an estimated $98 billion in sales over the past eight years by paying generic manufacturers to postpone selling low-cost generic drugs, according to a new report...
View ArticleClik here to view.
The Price of Gleevec: A Tale of Two Supreme Courts
Gleevec 400 mg tablets photo credit: Patrick Pelletier Creative Commons CC-BY-SA-3.0 Americans interested in generic drug prices and pharmaceutical patent law have been closely following the U.S....
View ArticleClik here to view.
Open Season on Pay-To-Delay After New Supreme Court Decision
This week, the U.S. Supreme Court ruled in favor of consumers over drug companies by ruling that pay-to-delay tactics by pharmaceutical companies could violate antitrust laws. This could mean speedier...
View ArticleClik here to view.
The Prices We Pay for Delay
Brand name drug manufacturers made an estimated $98 billion in sales over the past eight years by paying generic manufacturers to postpone selling low-cost generic drugs, according to a new report...
View Article
